{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:59:08Z","timestamp":1784318348800,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Translational Excellence in Regenerative Medicine (TeRM) SmartMix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science"},{"name":"Deutsche Forschungsgemeinschaft (DFG): international research training group","award":["GRK 880 Vascular Medicine, Mannheim"],"award-info":[{"award-number":["GRK 880 Vascular Medicine, Mannheim"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00125-018-4713-0","type":"journal-article","created":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T22:58:15Z","timestamp":1535324295000},"page":"2371-2385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Human adipose tissue-derived stromal cells act as functional pericytes in mice and suppress high-glucose-induced proinflammatory activation of bovine retinal endothelial cells"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7428-3312","authenticated-orcid":false,"given":"Ghazaleh","family":"Hajmousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Przybyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genaro A.","family":"Paredes-Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kondaiah","family":"Moganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja J. A.","family":"van Luyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Krenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Hammes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"4713_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2337\/diacare.26.1.226","volume":"26","author":"DS Fong","year":"2003","unstructured":"Fong DS, Cavallerano JD, Aiello L et al (2003) Diabetic retinopathy. Diabetes Care 26:226\u2013229","journal-title":"Diabetes Care"},{"key":"4713_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/archopht.122.4.552","volume":"122","author":"JH Kempen","year":"2004","unstructured":"Kempen JH, O'Colmam BJ, Leske C et al (2004) The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122:552\u2013563","journal-title":"Arch Ophthalmol"},{"key":"4713_CR3","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M (2005) The pathobiology of diabetic complications - a unifying mechanism. Diabetes 54:1615\u20131625","journal-title":"Diabetes"},{"key":"4713_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.mvr.2009.02.005","volume":"78","author":"Y Chen","year":"2009","unstructured":"Chen Y, Hu Y, Moiseyev G, Zhou KK, Chen DY, Ma JX (2009) Photoreceptor degeneration and retinal inflammation induced by very low-density lipoprotein receptor deficiency. Microvasc Res 78:119\u2013127","journal-title":"Microvasc Res"},{"key":"4713_CR5","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/sj.eye.6702138","volume":"20","author":"N Demircan","year":"2006","unstructured":"Demircan N, Safran BG, Soylu M, Ozcan AA, Sizmaz S (2006) Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 20:1366\u20131369","journal-title":"Eye"},{"key":"4713_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0002-9394(14)74052-8","volume":"114","author":"AM Abu el Asrar","year":"1992","unstructured":"Abu el Asrar AM, Maimone D, Morse PH, Gregory S, Reder AT (1992) Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol 114:731\u2013736","journal-title":"Am J Ophthalmol"},{"key":"4713_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3109\/02713689508998529","volume":"14","author":"SG Elner","year":"1995","unstructured":"Elner SG, Elner VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM (1995) Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 14:1045\u20131053","journal-title":"Curr Eye Res"},{"key":"4713_CR8","first-page":"155","volume":"17","author":"AM Abu El-Asrar","year":"2006","unstructured":"Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J (2006) Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur Cytokine Netw 17:155\u2013165","journal-title":"Eur Cytokine Netw"},{"key":"4713_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0002-9394(14)71072-4","volume":"123","author":"AM Abu el-Asrar","year":"1997","unstructured":"Abu el-Asrar AM, Van Damme J, Put W et al (1997) Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders. Am J Ophthalmol 123:599\u2013606","journal-title":"Am J Ophthalmol"},{"key":"4713_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2007\/95103","volume":"2007","author":"Timothy S. Kern","year":"2007","unstructured":"Kern TS (2007) Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res. \n                    https:\/\/doi.org\/10.1155\/2007\/95103","journal-title":"Experimental Diabetes Research"},{"key":"4713_CR11","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.1161\/01.RES.0000241051.83067.62","volume":"99","author":"T Szerafin","year":"2006","unstructured":"Szerafin T, Erdei N, Fulop T et al (2006) Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus. Circ Res 99:E12\u2013E17","journal-title":"Circ Res"},{"key":"4713_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ejphar.2004.07.046","volume":"498","author":"SP Ayalasomayajula","year":"2004","unstructured":"Ayalasomayajula SP, Amrite AC, Kompella UB (2004) Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E-2 secretion from diabetic rat retinas. Eur J Pharmacol 498:275\u2013278","journal-title":"Eur J Pharmacol"},{"key":"4713_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/db10-0454","volume":"60","author":"HP Hammes","year":"2011","unstructured":"Hammes HP, Feng YX, Pfister F, Brownlee M (2011) Diabetic retinopathy: targeting vasoregression. Diabetes 60:9\u201316","journal-title":"Diabetes"},{"key":"4713_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/01.RES.0000182903.16652.d7","volume":"97","author":"A Armulik","year":"2005","unstructured":"Armulik A, Abramsson A, Betsholtz C (2005) Endothelial\/pericyte interactions. Circ Res 97:512\u2013523","journal-title":"Circ Res"},{"key":"4713_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/14653240310003026","volume":"5","author":"JM Gimble","year":"2003","unstructured":"Gimble JM, Guilak F (2003) Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 5:362\u2013369","journal-title":"Cytotherapy"},{"key":"4713_CR16","doi-asserted-by":"publisher","first-page":"e84671","DOI":"10.1371\/journal.pone.0084671","volume":"9","author":"G Rajashekhar","year":"2014","unstructured":"Rajashekhar G, Ramadan A, Abburi C et al (2014) Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy. PLoS One 9:e84671","journal-title":"PLoS One"},{"key":"4713_CR17","doi-asserted-by":"publisher","first-page":"e65691","DOI":"10.1371\/journal.pone.0065691","volume":"8","author":"TA Mendel","year":"2013","unstructured":"Mendel TA, Clabough EBD, Kao DS et al (2013) Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy. PLoS One 8:e65691","journal-title":"PLoS One"},{"key":"4713_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/stem.2726","volume":"36","author":"V Terlizzi","year":"2018","unstructured":"Terlizzi V, Kolibabka M, Burgess JK, Hammes HP, Harmsen MC (2018) The pericytic phenotype of adipose tissue-derived stromal cells is promoted by NOTCH2. Stem Cells 36:240\u2013251","journal-title":"Stem Cells"},{"key":"4713_CR19","doi-asserted-by":"publisher","unstructured":"Fiori A, Terlizzi V, Kremer H et al (2018) Mesenchymal stromal\/stem cells as potential therapy in diabetic retinopathy. Immunobiology. \n                    https:\/\/doi.org\/10.1016\/j.imbio.2018.01.001","DOI":"10.1016\/j.imbio.2018.01.001"},{"key":"4713_CR20","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1089\/ten.tea.2008.0630","volume":"15","author":"O DelaRosa","year":"2009","unstructured":"DelaRosa O, Lombardo E, Beraza A et al (2009) Requirement of IFN-\u03b3-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng A 15:2795\u20132806","journal-title":"Tissue Eng A"},{"key":"4713_CR21","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815\u20131822","journal-title":"Blood"},{"key":"4713_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"GW Ren","year":"2008","unstructured":"Ren GW, Zhang LY, Zhao X et al (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2:141\u2013150","journal-title":"Cell Stem Cell"},{"key":"4713_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.trsl.2008.03.003","volume":"151","author":"F Gao","year":"2008","unstructured":"Gao F, Wu DQ, Hu YH et al (2008) In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells. Transl Res 151:293\u2013302","journal-title":"Transl Res"},{"key":"4713_CR24","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1182\/blood-2007-02-075481","volume":"110","author":"D Chabannes","year":"2007","unstructured":"Chabannes D, Hill M, Merieau E et al (2007) A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 110:3691\u20133694","journal-title":"Blood"},{"key":"4713_CR25","doi-asserted-by":"publisher","first-page":"e0165466","DOI":"10.1371\/journal.pone.0165466","volume":"11","author":"D Kadekar","year":"2016","unstructured":"Kadekar D, Rangole S, Kale V, Limaye L (2016) Conditioned medium from placental mesenchymal stem cells reduces oxidative stress during the cryopreservation of ex vivo expanded umbilical cord blood cells. PLoS One 11:e0165466","journal-title":"PLoS One"},{"key":"4713_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/1534734615569053","volume":"14","author":"MR Li","year":"2015","unstructured":"Li MR, Zhao YL, Hao HJ et al (2015) Mesenchymal stem cell-conditioned medium improves the proliferation and migration of keratinocytes in a diabetes-like microenvironment. Int J Lower Extrem Wounds 14:73\u201386","journal-title":"Int J Lower Extrem Wounds"},{"key":"4713_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biomaterials.2016.12.008","volume":"119","author":"G Hajmousa","year":"2017","unstructured":"Hajmousa G, Vogelaar P, Brouwer LA, van der Graaf AC, Henning RH, Krenning G (2017) The 6-chromanol derivate SUL-109 enables prolonged hypothermic storage of adipose tissue-derived stem cells. Biomaterials 119:43\u201352","journal-title":"Biomaterials"},{"key":"4713_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/scd.2008.0358","volume":"18","author":"S Iwashima","year":"2009","unstructured":"Iwashima S, Ozaki T, Maruyama S et al (2009) Novel culture system of mesenchymal stromal cells from human subcutaneous adipose tissue. Stem Cells Dev 18:533\u2013543","journal-title":"Stem Cells Dev"},{"key":"4713_CR29","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1089\/scd.2016.0025","volume":"25","author":"G Hajmousa","year":"2016","unstructured":"Hajmousa G, Elorza AA, Nies VJM, Jensen EL, Nagy RA, Harmsen MC (2016) Hyperglycemia induces bioenergetic changes in adipose-derived stromal cells while their pericytic function is retained. Stem Cells Dev 25:1444\u20131453","journal-title":"Stem Cells Dev"},{"key":"4713_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.exer.2011.12.003","volume":"96","author":"J Wisniewska-Kruk","year":"2012","unstructured":"Wisniewska-Kruk J, Hoeben KA, Vogels IMC et al (2012) A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes. Exp Eye Res 96:181\u2013190","journal-title":"Exp Eye Res"},{"key":"4713_CR31","first-page":"101","volume":"35","author":"LEH Smith","year":"1994","unstructured":"Smith LEH, Wesolowski E, Mclellan A et al (1994) Oxygen-induced retinopathy in the mouse. Investi Ophth Vis Sci 35:101\u2013111","journal-title":"Investi Ophth Vis Sci"},{"key":"4713_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nm0596-529","volume":"2","author":"HP Hammes","year":"1996","unstructured":"Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT (1996) Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med 2:529\u2013533","journal-title":"Nat Med"},{"key":"4713_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the \n                    \n                      \n                    \n                    \n                      \n                        \n                          2\n                          \n                            \u2212\n                            \u0394\u0394\n                            \n                              C\n                              t\n                            \n                          \n                        \n                      \n                    \n                    $$ {2}^{-\\varDelta \\varDelta {\\mathrm{C}}_{\\mathrm{t}}} $$\n                  method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"4713_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-60761-411-1_4","volume":"594","author":"E Eruslanov","year":"2010","unstructured":"Eruslanov E, Kusmartsev S (2010) Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol Biol 594:57\u201372","journal-title":"Methods Mol Biol"},{"key":"4713_CR35","doi-asserted-by":"publisher","first-page":"14623","DOI":"10.1038\/srep14623","volume":"5","author":"GA Paredes-Juarez","year":"2015","unstructured":"Paredes-Juarez GA, Sahasrabudhe NM, Tjoelker RS et al (2015) DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1. Sci Rep 5:14623","journal-title":"Sci Rep"},{"key":"4713_CR36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/emmm.201202382","volume":"5","author":"A Ortega-Gomez","year":"2013","unstructured":"Ortega-Gomez A, Perretti M, Soehnlein O (2013) Resolution of inflammation: an integrated view. EMBO Mol Med 5:661\u2013674","journal-title":"EMBO Mol Med"},{"key":"4713_CR37","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1172\/JCI111810","volume":"75","author":"PE Dicorleto","year":"1985","unstructured":"Dicorleto PE, Delamotte CA (1985) Characterization of the adhesion of the human monocytic cell-line U937 to cultured endothelial-cells. J Clin Investig 75:1153\u20131161","journal-title":"J Clin Investig"},{"key":"4713_CR38","first-page":"449","volume":"29","author":"RA Caruso","year":"2009","unstructured":"Caruso RA, Fedele F, Finocchiaro G et al (2009) Ultrastructural descriptions of pericyte\/endothelium peg-socket interdigitations in the microvasculature of human gastric carcinomas. Anticancer Res 29:449\u2013453","journal-title":"Anticancer Res"},{"key":"4713_CR39","first-page":"623","volume":"26","author":"L Diaz-Flores Jr","year":"2011","unstructured":"Diaz-Flores L Jr, Gutierrez R, Madrid JF et al (2011) Peg-and-socket junctions between smooth muscle cells and endothelial cells in femoral veins are stimulated to angiogenesis by prostaglandin E(2) and glycerols. Histol Histopathol 26:623\u2013630","journal-title":"Histol Histopathol"},{"key":"4713_CR40","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3727\/000000007783464939","volume":"16","author":"KA Keyser","year":"2007","unstructured":"Keyser KA, Beagles KE, Kiem HP (2007) Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant 16:555\u2013562","journal-title":"Cell Transplant"},{"key":"4713_CR41","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1634\/stemcells.2005-0235","volume":"24","author":"K McIntosh","year":"2006","unstructured":"McIntosh K, Zvonic S, Garrett S et al (2006) The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 24:1246\u20131253","journal-title":"Stem Cells"},{"key":"4713_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cellimm.2009.06.010","volume":"259","author":"KH Yoo","year":"2009","unstructured":"Yoo KH, Jang IK, Lee MW et al (2009) Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 259:150\u2013156","journal-title":"Cell Immunol"},{"key":"4713_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12015-010-9193-7","volume":"7","author":"B Lindroos","year":"2011","unstructured":"Lindroos B, Suuronen R, Miettinen S (2011) The potential of adipose stem cells in regenerative medicine. Stem Cell Rev Rep 7:269\u2013291","journal-title":"Stem Cell Rev Rep"},{"key":"4713_CR44","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1167\/iovs.10-5176","volume":"51","author":"A Stahl","year":"2010","unstructured":"Stahl A, Connor KM, Sapieha P et al (2010) The mouse retina as an angiogenesis model. Invest Ophth Vis Sci 51:2813\u20132826","journal-title":"Invest Ophth Vis Sci"},{"key":"4713_CR45","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1167\/iovs.07-1206","volume":"49","author":"J Cai","year":"2008","unstructured":"Cai J, Kehoe O, Smith GM, Hykin P, Boulton ME (2008) The angiopoietin\/tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. Invest Ophth Vis Sci 49:2163\u20132171","journal-title":"Invest Ophth Vis Sci"},{"key":"4713_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Armulik","year":"2011","unstructured":"Armulik A, Genove G, Betsholtz C (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21:193\u2013215","journal-title":"Dev Cell"},{"key":"4713_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0014-2999(02)02793-0","volume":"458","author":"SP Ayalasomayajula","year":"2003","unstructured":"Ayalasomayajula SP, Kompella UB (2003) Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model. Eur J Pharmacol 458:283\u2013289","journal-title":"Eur J Pharmacol"},{"key":"4713_CR48","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/01.CIR.0000080735.93327.00","volume":"108","author":"F Sennlaub","year":"2003","unstructured":"Sennlaub F, Valamanesh F, Vazquez-Tello A et al (2003) Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation 108:198\u2013204","journal-title":"Circulation"},{"key":"4713_CR49","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1074\/jbc.M703090200","volume":"283","author":"F Finetti","year":"2008","unstructured":"Finetti F, Solito R, Morbidelli L, Giachetti A, Ziche M, Donnini S (2008) Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1. J Biol Chem 283:2139\u20132146","journal-title":"J Biol Chem"},{"key":"4713_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.plefa.2013.04.004","volume":"89","author":"I Gomez","year":"2013","unstructured":"Gomez I, Foudi N, Longrois D, Norel X (2013) The role of prostaglandin E2 in human vascular inflammation. Prostaglandins Leukot Essent Fatty Acids 89:55\u201363","journal-title":"Prostaglandins Leukot Essent Fatty Acids"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4713-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4713-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4713-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T19:25:46Z","timestamp":1566847546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4713-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["4713"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4713-0","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,27]]},"assertion":[{"value":"3 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}